$ARVN
Arvinas Inc Stock $arvn

$arvn Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000165575922000027 Filed on August 04, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$30.30M	$31.30M	$24.20M
YoY Change	226.34%	469.09%	340.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$20.00M	$24.30M	$20.20M
YoY Change	24.9%	68.62%	63.96%
% of Gross Profit
Research & Development	$77.50M	$75.30M	$64.00M
YoY Change	90.87%	75.12%	83.38%
% of Gross Profit
Depreciation & Amortization	$1.600M	$1.500M	$1.500M
YoY Change	33.49%	28.93%	30.43%
% of Gross Profit
Operating Expenses	$97.50M	$99.60M	$84.20M
YoY Change	72.21%	73.52%	78.39%
Operating Profit	-$67.20M	-$68.30M	-$60.00M
YoY Change	42.07%	31.6%	43.88%
Interest Expense	$3.200M	$1.800M	$1.200M
YoY Change	787.85%	411.32%	179.07%
% of Operating Profit
Other Income/Expense, Net	$3.200M	$1.700M	$1.100M
YoY Change	1360.79%	6.25%	57.14%
Pretax Income	-$64.00M	-$66.60M	-$58.90M
YoY Change	36.89%	32.44%	43.8%
Income Tax	$2.200M	$3.400M	$4.500M
% Of Pretax Income
Net Earnings	-$66.20M	-$70.00M	-$63.40M
YoY Change	41.6%	39.17%	54.63%
Net Earnings / Revenue	-218.48%	-223.64%	-261.98%
Basic Earnings Per Share	-$1.24	-$1.32	-$1.20
Diluted Earnings Per Share	-$1.24	-$1.32	-$1.20
COMMON SHARES
Basic Shares Outstanding	53.21M shares	53.20M shares	53.00M shares
Diluted Shares Outstanding	53.20M shares	53.20M shares	53.00M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.271B	$1.343B	$1.428B
YoY Change	-17.73%	123.65%	119.32%
Cash & Equivalents	$132.6M	$93.20M	$62.30M
Short-Term Investments	$1.138B	$1.250B	$1.366B
Other Short-Term Assets	$27.20M	$25.10M	$21.90M
YoY Change	18.07%	27.13%	167.07%
Inventory
Prepaid Expenses
Receivables	$1.000M	$1.400M	$0.00
Other Receivables	$5.800M	$6.700M	$6.700M
Total Short-Term Assets	$1.305B	$1.376B	$1.457B
YoY Change	-17.22%	119.26%	119.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.00M	$13.60M	$13.40M
YoY Change	20.4%	16.24%	9.74%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$11.30M	$11.70M	$12.10M
YoY Change	-11.97%	40553.23%
Total Long-Term Assets	$30.10M	$30.60M	$31.30M
YoY Change	4.83%	87.81%	83.04%
TOTAL ASSETS
Total Short-Term Assets	$1.305B	$1.376B	$1.457B
Total Long-Term Assets	$30.10M	$30.60M	$31.30M
Total Assets	$1.335B	$1.407B	$1.488B
YoY Change	-16.83%	118.47%	118.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.900M	$12.30M	$8.600M
YoY Change	69.11%	147.22%	-4.44%
Accrued Expenses	$1.800M	$31.50M	$30.20M
YoY Change	-86.93%	133.8%	277.44%
Deferred Revenue	$193.1M	$194.4M	$197.5M
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$244.6M	$238.2M	$238.0M
YoY Change	34.02%	469.58%	489.11%
LONG-TERM LIABILITIES
Long-Term Debt	$1.000M	$1.000M	$1.000M
YoY Change	0.0%	0.0%	-50.0%
Other Long-Term Liabilities	$467.7M	$497.2M	$526.0M
YoY Change	-22.52%	2622.99%	2082.57%
Total Long-Term Liabilities	$1.000M	$1.000M	$1.000M
YoY Change	-99.83%	-94.81%	-96.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$244.6M	$238.2M	$238.0M
Total Long-Term Liabilities	$1.000M	$1.000M	$1.000M
Total Liabilities	$713.3M	$736.4M	$765.0M
YoY Change	-9.38%	1105.64%	1050.38%
SHAREHOLDERS EQUITY
Retained Earnings	-$882.5M	-$816.3M	-$746.3M
YoY Change
Common Stock	$100.0K	$100.0K	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$621.5M	$670.6M	$723.3M
YoY Change
Total Liabilities & Shareholders Equity	$1.335B	$1.407B	$1.488B
YoY Change	-16.83%	118.47%	118.29%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$66.20M	-$70.00M	-$63.40M
YoY Change	41.6%	39.17%	54.63%
Depreciation, Depletion And Amortization	$1.600M	$1.500M	$1.500M
YoY Change	33.49%	28.93%	30.43%
Cash From Operating Activities	-$66.60M	-$78.60M	-$57.10M
YoY Change	-109.77%	65.82%	46.41%
INVESTING ACTIVITIES
Capital Expenditures	-$2.200M	-$1.400M	$2.100M
YoY Change	63.2%	199.83%	110.0%
Acquisitions
YoY Change
Other Investing Activities	$108.0M	$110.4M	$10.70M
YoY Change	-114.6%	-144.41%	-105.17%
Cash From Investing Activities	$105.8M	$109.0M	$8.600M
YoY Change	-114.28%	-143.77%	-104.14%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.200M	500.0K	$2.500M
YoY Change	-99.55%	-86.16%	-44.44%
NET CHANGE
Cash From Operating Activities	-66.60M	-78.60M	-$57.10M
Cash From Investing Activities	105.8M	109.0M	$8.600M
Cash From Financing Activities	1.200M	500.0K	$2.500M
Net Change In Cash	40.40M	30.90M	-$46.00M
YoY Change	-80.48%	-110.55%	-81.02%
FREE CASH FLOW
Cash From Operating Activities	-$66.60M	-$78.60M	-$57.10M
Capital Expenditures	-$2.200M	-$1.400M	$2.100M
Free Cash Flow	-$64.40M	-$77.20M	-$59.20M
YoY Change	-109.43%	64.48%	48.0%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
	dei	Entity Central Index Key EntityCentralIndexKey	0001655759
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P6M
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38672
	dei	Entity Registrant Name EntityRegistrantName	ARVINAS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-2566120
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5 Science Park
	dei	Entity Address Address Line2 EntityAddressAddressLine2	395 Winchester Ave
	dei	Entity Address City Or Town EntityAddressCityOrTown	New Haven
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06511
	dei	City Area Code CityAreaCode	203
	dei	Local Phone Number LocalPhoneNumber	535-1456
	dei	Security12b Title Security12bTitle	Common stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	ARVN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	53205299	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	93200000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	108300000	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	4500000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	4500000	usd
CY2022Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1250000000	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1394300000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1400000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15000000.0	usd
CY2022Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	6700000	usd
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	10700000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	20600000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19700000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1376400000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1552500000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13600000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12700000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5300000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3900000	usd
CY2022Q2	arvn	Collaboration Contract Asset And Other Assets CollaborationContractAssetAndOtherAssets	11700000	usd
CY2021Q4	arvn	Collaboration Contract Asset And Other Assets CollaborationContractAssetAndOtherAssets	12500000	usd
CY2022Q2	us-gaap	Assets Assets	1407000000	usd
CY2021Q4	us-gaap	Assets Assets	1581600000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	42100000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	54400000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	194400000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	206200000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1700000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1100000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	238200000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	261700000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	493600000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	534300000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000.0	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000.0	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3600000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2900000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	736400000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	799900000	usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53200000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53200000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	53000000.0	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	53000000.0	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	100000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-816300000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-682900000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1508800000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1469200000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-22000000.0	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4600000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	670600000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	781700000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1407000000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1581600000	usd
CY2022Q2	us-gaap	Revenues Revenues	31300000	usd
CY2021Q2	us-gaap	Revenues Revenues	5500000	usd
	us-gaap	Revenues Revenues	55500000	usd
	us-gaap	Revenues Revenues	11100000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	75300000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43000000.0	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	139200000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	77900000	usd
CY2022Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	24300000	usd
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14400000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	44500000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	26700000	usd
CY2022Q2	us-gaap	Operating Expenses OperatingExpenses	99600000	usd
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	57400000	usd
	us-gaap	Operating Expenses OperatingExpenses	183700000	usd
	us-gaap	Operating Expenses OperatingExpenses	104600000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-68300000	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-51900000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-128200000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-93500000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-100000	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1200000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-200000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1400000	usd
CY2022Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1800000	usd
CY2021Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	400000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2900000	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	800000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1700000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1600000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2700000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2200000	usd
CY2022Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-66600000	usd
CY2021Q2	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-50300000	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-125500000	usd
	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-91300000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3400000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7900000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-70000000.0	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-50300000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-133400000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-91300000	usd
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.32
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.32
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.03
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.51
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.51
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.87
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.87
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53200000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53200000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48900000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48900000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53100000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53100000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48700000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48700000	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-70000000.0	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-50300000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-133400000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-91300000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-3300000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-200000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-17400000	usd
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-1000000.0	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-73300000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-50500000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-150800000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-92300000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	723300000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20000000.0	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-70000000.0	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	600000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-3300000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	670600000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	615200000	usd
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14600000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-50300000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3600000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-200000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	582900000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	781700000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	36600000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-133400000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3100000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-17400000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	670600000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	642200000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	24900000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-91300000	usd
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	0	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	8100000	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-1000000.0	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	582900000	usd
	us-gaap	Profit Loss ProfitLoss	-133400000	usd
	us-gaap	Profit Loss ProfitLoss	-91300000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3000000.0	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2300000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-5800000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-2700000	usd
	arvn	Debt Instrument Loan Forgiveness DebtInstrumentLoanForgiveness	0	usd
	arvn	Debt Instrument Loan Forgiveness DebtInstrumentLoanForgiveness	1000000.0	usd
	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	-100000	usd
	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	0	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1000000.0	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	600000	usd
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	800000	usd
	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	36600000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	24900000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-13600000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1000000.0	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-4000000.0	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	0	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1000000.0	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9100000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-12700000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-7800000	usd
	arvn	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-1000000.0	usd
	arvn	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-600000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-52500000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-8100000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-135700000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-86400000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	469100000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	538000000.0	usd
	arvn	Proceeds From Maturities Of Marketable Securities ProceedsFromMaturitiesOfMarketableSecurities	555900000	usd
	arvn	Proceeds From Maturities Of Marketable Securities ProceedsFromMaturitiesOfMarketableSecurities	82600000	usd
	arvn	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	34300000	usd
	arvn	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	0	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3500000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1500000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	117600000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-456900000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3000000.0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	8100000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3000000.0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8100000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-15100000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-535200000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	112800000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	588400000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	97700000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53200000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	500000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	300000	usd
CY2022Q2	arvn	Cash Cash Equivalents Restricted Cash And Marketable Securities CashCashEquivalentsRestrictedCashAndMarketableSecurities	1300000000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	15000000.0	usd
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
	arvn	Accounts Receivable After Allowance For Credit Loss Current Additions AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions	1400000	usd
	arvn	Accounts Receivable After Allowance For Credit Loss Current Additions AccountsReceivableAfterAllowanceForCreditLossCurrentAdditions	0	usd
	arvn	Accounts Receivable After Allowance For Credit Loss Current Payments Received AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived	15000000.0	usd
	arvn	Accounts Receivable After Allowance For Credit Loss Current Payments Received AccountsReceivableAfterAllowanceForCreditLossCurrentPaymentsReceived	0	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1400000	usd
CY2021Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	0	usd
CY2021Q4	arvn	Collaboration Contract Asset And Other Assets CollaborationContractAssetAndOtherAssets	12500000	usd
CY2020Q4	arvn	Collaboration Contract Asset And Other Assets CollaborationContractAssetAndOtherAssets	0	usd
	arvn	Collaboration Contract Asset And Other Assets Period Increase Decrease CollaborationContractAssetAndOtherAssetsPeriodIncreaseDecrease	-800000	usd
	arvn	Collaboration Contract Asset And Other Assets Period Increase Decrease CollaborationContractAssetAndOtherAssetsPeriodIncreaseDecrease	0	usd
CY2022Q2	arvn	Collaboration Contract Asset And Other Assets CollaborationContractAssetAndOtherAssets	11700000	usd
CY2021Q2	arvn	Collaboration Contract Asset And Other Assets CollaborationContractAssetAndOtherAssets	0	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	740500000	usd
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	45100000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-55500000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-11100000	usd
	arvn	Contract With Customer Liability Increase Decrease For Additions To Collaboration Agreements ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements	3000000.0	usd
	arvn	Contract With Customer Liability Increase Decrease For Additions To Collaboration Agreements ContractWithCustomerLiabilityIncreaseDecreaseForAdditionsToCollaborationAgreements	3000000.0	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	688000000.0	usd
CY2021Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	37000000.0	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	688000000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	101100000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	190000000.0	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	136500000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	100400000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	63400000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	34100000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	62500000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	688000000.0	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	27300000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	23400000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	13700000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10700000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13600000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12700000	usd
CY2022Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1500000	usd
CY2021Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1200000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3000000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2300000	usd
CY2021Q2	us-gaap	Land Subject To Ground Leases LandSubjectToGroundLeases	160000	sqft
CY2021Q2	arvn	Base Lease Rent Period BaseLeaseRentPeriod	P10Y
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y7M6D
CY2022Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	500000	usd
CY2021Q2	us-gaap	Operating Lease Cost OperatingLeaseCost	300000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1100000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	700000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1000000.0	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	600000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2400000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3200000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	800000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2100000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2100000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	500000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	0	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5500000	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	200000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	5300000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	12300000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	31300000	usd
CY2022Q2	arvn	Accrued Research And Development Expense Current AccruedResearchAndDevelopmentExpenseCurrent	18900000	usd
CY2021Q4	arvn	Accrued Research And Development Expense Current AccruedResearchAndDevelopmentExpenseCurrent	9500000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8700000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12400000	usd
CY2022Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	2200000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1200000	usd
CY2022Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	42100000	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	54400000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1000000	usd
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	0	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	200000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	200000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	200000	usd
CY2022Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	200000	usd
CY2022Q2	arvn	Long Term Debt Maturity Year Six LongTermDebtMaturityYearSix	200000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	1000000.0	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	41.41
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	7100000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3400000	usd
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.052
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2021Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
CY2022Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2022Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.052
CY2021Q2	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7900000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.063
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.063
	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0000
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-70000000.0	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-50300000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-133400000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-91300000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53200000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53200000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48900000	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48900000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53100000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53100000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48700000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48700000	shares
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.32
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.32
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.03
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.51
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.51
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.87
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.87
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6800000	shares
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6800000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5600000	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5600000	shares

Files In Submission

Name	View Source	Status
0001655759-22-000027-index-headers.html	Edgar Link	pending
0001655759-22-000027-index.html	Edgar Link	pending
0001655759-22-000027.txt	Edgar Link	pending
0001655759-22-000027-xbrl.zip	Edgar Link	pending
arvinasfmicdxagreementre.htm	Edgar Link	pending
arvinasfmicdxagreementre001.jpg	Edgar Link	pending
arvinasfmicdxagreementre002.jpg	Edgar Link	pending
arvinasfmicdxagreementre003.jpg	Edgar Link	pending
arvinasfmicdxagreementre004.jpg	Edgar Link	pending
arvinasfmicdxagreementre005.jpg	Edgar Link	pending
arvinasfmicdxagreementre006.jpg	Edgar Link	pending
arvinasfmicdxagreementre007.jpg	Edgar Link	pending
arvinasfmicdxagreementre008.jpg	Edgar Link	pending
arvinasfmicdxagreementre009.jpg	Edgar Link	pending
arvinasfmicdxagreementre010.jpg	Edgar Link	pending
arvinasfmicdxagreementre011.jpg	Edgar Link	pending
arvinasfmicdxagreementre012.jpg	Edgar Link	pending
arvinasfmicdxagreementre013.jpg	Edgar Link	pending
arvinasfmicdxagreementre014.jpg	Edgar Link	pending
arvinasfmicdxagreementre015.jpg	Edgar Link	pending
arvinasfmicdxagreementre016.jpg	Edgar Link	pending
arvinasfmicdxagreementre017.jpg	Edgar Link	pending
arvinasfmicdxagreementre018.jpg	Edgar Link	pending
arvinasfmicdxagreementre019.jpg	Edgar Link	pending
arvinasfmicdxagreementre020.jpg	Edgar Link	pending
arvinasfmicdxagreementre021.jpg	Edgar Link	pending
arvinasfmicdxagreementre022.jpg	Edgar Link	pending
arvinasfmicdxagreementre023.jpg	Edgar Link	pending
arvinasfmicdxagreementre024.jpg	Edgar Link	pending
arvinasfmicdxagreementre025.jpg	Edgar Link	pending
arvinasfmicdxagreementre026.jpg	Edgar Link	pending
arvinasfmicdxagreementre027.jpg	Edgar Link	pending
arvinasfmicdxagreementre028.jpg	Edgar Link	pending
arvinasfmicdxagreementre029.jpg	Edgar Link	pending
arvinasfmicdxagreementre030.jpg	Edgar Link	pending
arvinasfmicdxagreementre031.jpg	Edgar Link	pending
arvinasfmicdxagreementre032.jpg	Edgar Link	pending
arvinasfmicdxagreementre033.jpg	Edgar Link	pending
arvn-20220630.htm	Edgar Link	pending
arvn-20220630.xsd	Edgar Link	pending
arvn-20220630x10qex311.htm	Edgar Link	pending
arvn-20220630x10qex312.htm	Edgar Link	pending
arvn-20220630x10qex321.htm	Edgar Link	pending
arvn-20220630x10qex322.htm	Edgar Link	pending
arvn-20220630_cal.xml	Edgar Link	unprocessable
arvn-20220630_def.xml	Edgar Link	unprocessable
arvn-20220630_htm.xml	Edgar Link	completed
arvn-20220630_lab.xml	Edgar Link	unprocessable
arvn-20220630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ARVN
Arvinas Inc Stock $arvn

2022 Q3 Form 10-Q Financial Statement

#000165575922000027 Filed on August 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARVN Arvinas Inc Stock $arvn

2022 Q3 Form 10-Q Financial Statement

#000165575922000027 Filed on August 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ARVN
Arvinas Inc Stock $arvn